Using tandem mass spectrometry in targeted mode to identify activators of class IA PI3K in cancer.
Yang X, Turke AB, Qi J, Song Y, Rexer BN, Miller TW, Jänne PA, Arteaga CL, Cantley LC, Engelman JA, et al. Cancer Res. 2011 Sep 15; 71(18):5965-75. Epub 2011 Jul 20.